John R Leone's Net Worth
$505 Thousand
Who is John R Leone?
John R Leone does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include WINDTREE THERAPEUTICS INC /DE/, CAMBREX CORP, PERNIX THERAPEUTICS HOLDINGS, INC., VIROPHARMA INC, INKINE PHARMACEUTICAL CO INC, OSCIENT PHARMACEUTICALS CORP, and ORTEC INTERNATIONAL INC.
SEC CIK
John R Leone's CIK is 0001301047
Past Insider Trading and Trends
2006 was John R Leone's most active year for acquiring shares with 6 total transactions. John R Leone's most active month to acquire stocks was the month of January. 2014 was John R Leone's most active year for disposing of shares, totalling 11 transactions. John R Leone's most active month to dispose stocks was the month of December. 2006 saw John R Leone paying a total of $24,508.48 for 45,194 shares, this is the most they've acquired in one year. In 2014 John R Leone cashed out on 145,500 shares for a total of $550,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
WINDTREE THERAPEUTICS INC /DE/ (WINT) Snapshot price: $0.36
InvestorJohn R Leone owns 7,473 units of Common Stock which is worth $2,690.28. From 2012 to 2021 John R Leone acquired a total of 118,690 shares in WINDTREE THERAPEUTICS INC /DE/ at a cost of $23,640.25.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
| +38.29% | 2.07K |
$7.25 | $15,000.25 | 7.47K |
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
| +1,237.62% | 15K |
—
|
—
| 16.21K |
Dec 24
| |||
Form 4
| +115.66% | 650 |
—
|
—
| 1.21K |
Nov 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
| +63.00% | 4.35K |
—
|
—
| 11.25K |
Aug 4
| |||
Form 4
| +20.85% | 16.67K |
—
|
—
| 96.62K |
Aug 14
| |||
Form 4
| +166.91% | 50K |
—
|
—
| 79.96K |
Jul 22
| |||
Form 4
| +287.33% | 22.22K |
—
|
—
| 29.96K |
Jun 18
| |||
Form 4
| +157.80% | 4.73K |
—
|
—
| 7.73K |
Jun 11
| |||
Form 4
|
∞
| 3K |
$2.88 | $8,640.00 | 3K |
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CAMBREX CORP No price found
President & CEOJohn R Leone owns 120,047 units of Common Stock. From 2004 to 2006 John R Leone acquired a total of 119,801 shares in CAMBREX CORP.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +7.51% | 8.38K |
—
|
—
| 120.05K |
Dec 31 - Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 4
| +247,591.11% | 111.42K |
—
|
—
| 111.46K |
Aug 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PERNIX THERAPEUTICS HOLDINGS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VIROPHARMA INC No price found
InvestorJohn R Leone used to own units in Common Stock but no longer holds any shares there. From 2006 to 2014 John R Leone acquired a total of 11,000 shares in VIROPHARMA INC at a cost of $24,508.48, John also disposed a total of 11,000 shares of VIROPHARMA INC equalling to $550,000.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -11.00K |
$50.00 | -$550,000.00 |
0
|
Jan 24
| |||
Form 4
| +69.23% | 4.5K |
—
|
—
| 11K |
Feb 22
| |||
Form 4
| +225.00% | 4.5K |
—
|
—
| 6.5K |
Feb 21 - Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
|
∞
| 2K |
$12.25 | $24,508.48 | 2K |
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INKINE PHARMACEUTICAL CO INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
| No matching records found | |||||||||